Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph3 St of Durvalumab in Comb w Chemo and Bevac, Fol by Maint Durval, Bevac and Olaparib in Ovarian C

Protocol: OSU-18295

Full Title

A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O)

Gynecologic Cancers Ovarian Cancer